Effects of Supervised Exercise Training on Erythrocyte Deformability in Hemodialysis Patients
1 other identifier
interventional
63
1 country
1
Brief Summary
This study evaluated red blood cell function and aerobic capacity in adults receiving maintenance hemodialysis and in healthy reference participants. Participants receiving hemodialysis were included in either a supervised exercise training group or a usual-care group. The supervised exercise program combined resistance and aerobic exercise performed before hemodialysis. Participants in the exercise group completed repeated assessments across a non-exercise observation period, exercise training, and post-training follow-up. The usual-care group continued usual care without supervised exercise training, and healthy participants served as a reference group. Assessments included cardiopulmonary exercise testing and blood sampling to evaluate aerobic capacity, red blood cell deformability, and red blood cell characteristics related to membrane function, cell shape, oxidative stress, and calcium-related responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2025
CompletedFirst Submitted
Initial submission to the registry
September 12, 2026
CompletedFirst Posted
Study publicly available on registry
September 23, 2026
CompletedSeptember 23, 2026
September 1, 2026
3.3 years
September 12, 2026
September 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in Maximal Erythrocyte Elongation Index (EImax)
Maximal erythrocyte elongation index (EImax) was derived from ektacytometry measurements obtained across increasing shear stress.
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Change in Shear Stress at One-Half Maximal Erythrocyte Deformation (SS1/2)
The shear stress required to achieve one-half of maximal erythrocyte deformation (SS1/2) was derived from ektacytometry measurements across increasing shear stress.
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Change in Hypertonic Osmolality at 50% of Maximal Elongation Index (Ohyper)
Ohyper was assessed by osmotic-gradient ektacytometry and defined as the hypertonic osmolality at 50% of maximal erythrocyte elongation index.
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Change in Osmolality at Maximal Elongation Index (Omax)
Omax was assessed by osmotic-gradient ektacytometry and defined as the osmolality at maximal erythrocyte elongation index.
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Change in Osmoscan Area Under the Elongation Index-Osmolality Curve
Osmoscan area was assessed by osmotic-gradient ektacytometry and defined as the area under the erythrocyte elongation index-osmolality curve.
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Secondary Outcomes (5)
Change in Peak Oxygen Uptake (Peak VO₂/kg) Assessed by Cardiopulmonary Exercise Testing
Baseline; 3 months after baseline; after 36 supervised exercise sessions (mid-training); after 72 supervised exercise sessions (end of training); and 3 months after training cessation
Change in Erythrocyte Cellular Characteristics
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Change in Gardos-Related Erythrocyte Deformability Response
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Change in Erythrocyte Intracellular Calcium Response to Oxidative Stress
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Change in Erythrocyte Side-Scatter Response to Oxidative Stress
Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation
Study Arms (3)
Supervised Exercise Training
EXPERIMENTALParticipants receiving maintenance hemodialysis underwent supervised pre-dialysis exercise training combining aerobic and resistance exercise. Training was performed two to three times per week, with a target of 72 supervised sessions.
Usual Care
NO INTERVENTIONParticipants receiving maintenance hemodialysis continued usual medical care and maintained their usual daily activities without supervised exercise training during the intervention period.
Healthy Reference
NO INTERVENTIONHealthy participants without kidney disease received no exercise intervention and underwent study assessments to provide reference data for physiological and red blood cell measurements.
Interventions
Supervised pre-dialysis exercise training combining aerobic and resistance exercise was performed two to three times per week. Each session included aerobic exercise using a cycle ergometer, recumbent stepper, or treadmill, together with resistance exercises targeting the upper limbs, lower limbs, and trunk. Exercise intensity was prescribed according to cardiopulmonary exercise testing and adjusted according to participant tolerance and clinical status. Training was conducted approximately 1 to 2 hours before hemodialysis, with a target of 72 supervised exercise sessions.
Eligibility Criteria
You may qualify if:
- Age 20 years or older
- For participants with end-stage renal disease: maintenance hemodialysis for more than 6 months, clinically stable during the previous 3 months, stable medical treatment for at least 6 weeks, nephrologist approval for participation, and Kt/V \>1.2.
- For healthy reference participants: no history of kidney disease.
- Willingness to provide written informed consent.
You may not qualify if:
- Hyperkalemia within the previous 3 months.
- Orthopedic disease, muscle weakness, or other medical, physiological, or psychological conditions preventing exercise training or exercise testing.
- Pregnancy or planned pregnancy within 1 year.
- Implanted cardiac devices that prevented achievement of the heart rate required for exercise training.
- Cardiovascular, metabolic, or other clinical contraindications to exercise testing or training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Asia Universitylead
- Ministry of Science and Technology, Taiwancollaborator
Study Sites (1)
Chang Gung Memorial Hospital
Taoyuan, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 12, 2026
First Posted
September 23, 2026
Study Start
August 24, 2022
Primary Completion
December 28, 2025
Study Completion
December 28, 2025
Last Updated
September 23, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share